Last 12 months
Inside the activity.
1 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2026 Filed Oct 14, 2026 01:07 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
SaleCommon Stock | 57,264 | $0.95 | $54,400.80 |
DisclosureSEC source: 0001628280-26-065797 · wk-form4_1791940019.xml · nonDerivative · entry 2 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By: KVM Holdings, LLC Disclosed balance after: 1,030,771 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026 F3 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.90 to $0.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC. Read SEC document |
| October 09, 2026 Filed Oct 14, 2026 01:07 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
SaleCommon Stock | 468,727 | $0.95 | $445,290.65 |
DisclosureSEC source: 0001628280-26-065797 · wk-form4_1791940019.xml · nonDerivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,018,470 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026 F2 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.90 to $0.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| September 09, 2026 Filed Sep 12, 2026 01:13 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
SaleCommon Stock | 57,264 | $1.12 | $64,135.68 |
DisclosureSEC source: 0001628280-26-061626 · wk-form4_1789175624.xml · nonDerivative · entry 2 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By: KVM Holdings, LLC Disclosed balance after: 1,088,035 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026 F3 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.11 to $1.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC. Read SEC document |
| September 09, 2026 Filed Sep 12, 2026 01:13 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
SaleCommon Stock | 468,727 | $1.12 | $524,974.24 |
DisclosureSEC source: 0001628280-26-061626 · wk-form4_1789175624.xml · nonDerivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,487,197 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026 F2 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.06 to $1.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:13 UTC |
Johnson-Greene Treerita EssalimaChief Financial Officer
|
PurchaseCommon Stock | 21,000 | $1.23 | $25,830.00 |
DisclosureSEC source: 0001628280-26-043886 · wk-form4_1781727229.xml · nonDerivative · entry 1 Johnson-Greene Treerita Essalima · CIK 0002113708 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 521,000 Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:32 UTC |
Castillo KirstenDirector
|
GrantStock Option (Right to Buy) · Derivative | 170,100 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001104659-26-074073 · tm2617964-3_4seq1.xml · derivative · entry 1 Castillo Kirsten · CIK 0001808806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,100 Underlying: Common Stock · 170,100 shares Expires 2036-06-11 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:30 UTC |
Coleman BlaiseDirector
|
GrantStock Option (Right to Buy) · Derivative | 170,100 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001104659-26-074064 · tm2617964-1_4seq1.xml · derivative · entry 1 Coleman Blaise · CIK 0001689280 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,100 Underlying: Common Stock · 170,100 shares Expires 2036-06-11 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:35 UTC |
Kompella UdayDirector
|
GrantStock Option (Right to Buy) · Derivative | 170,100 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001104659-26-074078 · tm2617964-5_4seq1.xml · derivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,100 Underlying: Common Stock · 170,100 shares Expires 2036-06-11 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:33 UTC |
Chandrasekhar SatishchandranDirector
|
GrantStock Option (Right to Buy) · Derivative | 170,100 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001104659-26-074076 · tm2617964d4_4seq1.xml · derivative · entry 1 Chandrasekhar Satishchandran · CIK 0001832285 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,100 Underlying: Common Stock · 170,100 shares Expires 2036-06-11 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:31 UTC |
Zhang JungeDirector
|
GrantStock Option (Right to Buy) · Derivative | 170,100 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001104659-26-074072 · tm2617964-2_4seq1.xml · derivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,100 Underlying: Common Stock · 170,100 shares Expires 2036-06-11 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 01:26 UTC |
Zhang JungeDirector
|
Exercise / conversionOption (right to buy) · Derivative | 66,929 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001104659-26-039361 · tm2611053-1_4seq1.xml · derivative · entry 6 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 66,929 shares Expires 2034-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing a right to purchase 66,929 shares, vested and became exercisable on June 28, 2025. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 01:26 UTC |
Zhang JungeDirector
|
Exercise / conversionOption (right to buy) · Derivative | 112,205 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001104659-26-039361 · tm2611053-1_4seq1.xml · derivative · entry 5 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,205 shares Expires 2033-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a right to purchase 112,205 shares, vested and became exercisable on June 9, 2024. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 01:26 UTC |
Zhang JungeDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001104659-26-039361 · tm2611053-1_4seq1.xml · derivative · entry 4 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, initially representing a right to purchase 54,000 shares, vested and became exercisable in equal installments over three years commencing on January 2, 2020. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 01:26 UTC |
Zhang JungeDirector
|
Exercise / conversionCommon Stock | 66,929 | $1.42 | $95,039.18 |
DisclosureSEC source: 0001104659-26-039361 · tm2611053-1_4seq1.xml · nonDerivative · entry 3 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,359,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 01:26 UTC |
Zhang JungeDirector
|
Exercise / conversionCommon Stock | 112,205 | $0.46 | $51,614.30 |
DisclosureSEC source: 0001104659-26-039361 · tm2611053-1_4seq1.xml · nonDerivative · entry 2 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,292,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 01:26 UTC |
Zhang JungeDirector
|
Exercise / conversionCommon Stock | 15,000 | $0.51 | $7,650.00 |
DisclosureSEC source: 0001104659-26-039361 · tm2611053-1_4seq1.xml · nonDerivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,180,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 17:20 UTC |
Ramachandran RameshChief Accounting Officer
|
GrantOption (Right to Buy) · Derivative | 310,950 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001470831-26-000019 · form4.xml · derivative · entry 2 Ramachandran Ramesh · CIK 0002043659 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,950 Underlying: Common Stock · 310,950 shares Expires 2036-01-02 F2 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 2, 2027, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 17:20 UTC |
Ramachandran RameshChief Accounting Officer
|
GrantCommon Stock | 207,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000019 · form4.xml · nonDerivative · entry 1 Ramachandran Ramesh · CIK 0002043659 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,100 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest annually in three equal installments commencing on January 2, 2027, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:20 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
GrantOption (Right to Buy) · Derivative | 3,123,201 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001470831-26-000020 · form4.xml · derivative · entry 3 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,123,201 Underlying: Common Stock · 3,123,201 shares Expires 2036-01-02 F3 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 2, 2027, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:20 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
GrantCommon Stock | 3,123,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000020 · form4.xml · nonDerivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,955,924 F1 · kind: Reflects a grant of performance stock units ("PSUs"). Each PSU represents a contingent right to receive one share of the Issuer's common stock upon the achievement of certain performance goals, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 21:19 UTC |
Castillo KirstenDirector
|
GrantOption (Right to Buy) · Derivative | 151,316 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001062993-25-011273 · form4.xml · derivative · entry 1 Castillo Kirsten · CIK 0001808806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,316 Underlying: Common Stock · 151,316 shares Expires 2035-06-05 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 5, 2026 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 21:19 UTC |
Coleman BlaiseDirector
|
GrantOption (Right to Buy) · Derivative | 151,316 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001062993-25-011274 · form4.xml · derivative · entry 1 Coleman Blaise · CIK 0001689280 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,316 Underlying: Common Stock · 151,316 shares Expires 2035-06-05 F1 · derivative.exercise_date: The option vests monthly in equal installments over three years commencing on July 5, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 21:19 UTC |
Chandrasekhar SatishchandranDirector
|
GrantOption (Right to Buy) · Derivative | 151,316 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001062993-25-011275 · form4.xml · derivative · entry 1 Chandrasekhar Satishchandran · CIK 0001832285 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,316 Underlying: Common Stock · 151,316 shares Expires 2035-06-05 F1 · derivative.exercise_date: The option vests monthly in equal installments over three years commencing on July 5, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 21:18 UTC |
Kompella UdayDirector
|
GrantOption (Right to Buy) · Derivative | 151,316 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001062993-25-011272 · form4.xml · derivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,316 Underlying: Common Stock · 151,316 shares Expires 2035-06-05 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 5, 2026 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 21:18 UTC |
Zhang JungeDirector
|
GrantOption (Right to Buy) · Derivative | 151,316 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001062993-25-011271 · form4.xml · derivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,316 Underlying: Common Stock · 151,316 shares Expires 2035-06-05 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 5, 2026 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| January 03, 2025 Filed Jan 6, 2025 22:02 UTC |
Upadhyay ArunSee Remarks
|
Tax withholdingCommon Stock | 41,633 | $0.89 | $37,240.72 |
DisclosureSEC source: 0001062993-25-000406 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,197 Read SEC document |
| January 03, 2025 Filed Jan 6, 2025 22:01 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 177,146 | $0.89 | $158,457.10 |
DisclosureSEC source: 0001062993-25-000405 · form4.xml · nonDerivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,832,723 Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 17:02 UTC |
Ramachandran RameshChief Accounting Officer
|
GrantOption (Right to Buy) · Derivative | 350,146 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001062993-25-000408 · form4.xml · derivative · entry 1 Ramachandran Ramesh · CIK 0002043659 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,146 Underlying: Common Stock · 350,146 shares Expires 2035-01-02 F1 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 17:01 UTC |
Qamar HumaChief Medical Officer
|
GrantOption (Right to Buy) · Derivative | 1,145,468 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001062993-25-000404 · form4.xml · derivative · entry 1 Qamar Huma · CIK 0002015296 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,145,468 Underlying: Common Stock · 1,145,468 shares Expires 2035-01-02 F1 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:02 UTC |
Upadhyay ArunSee Remarks
|
GrantOption (Right to Buy) · Derivative | 730,994 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001062993-25-000406 · form4.xml · derivative · entry 2 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 730,994 Underlying: Common Stock · 730,994 shares Expires 2035-01-02 F1 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:01 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
GrantOption (Right to Buy) · Derivative | 1,827,485 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001062993-25-000405 · form4.xml · derivative · entry 3 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,827,485 Underlying: Common Stock · 1,827,485 shares Expires 2035-01-02 F2 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| November 26, 2024 Filed Dec 2, 2024 21:15 UTC |
Fernandes PrabhavathiDirector
|
PurchaseCommon Stock | 10,000 | $0.91 | $9,095.00 |
DisclosureSEC source: 0001104659-24-124587 · tm2429834-1_4seq1.xml · nonDerivative · entry 1 Fernandes Prabhavathi · CIK 0001540883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9042 to $0.9145. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 21:50 UTC |
Castillo KirstenDirector
|
PurchaseCommon Stock | 25,000 | $0.91 | $22,847.50 |
DisclosureSEC source: 0001062993-24-019706 · form4.xml · nonDerivative · entry 1 Castillo Kirsten · CIK 0001808806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9138 to $0.9139. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2024 Filed Sep 26, 2024 20:27 UTC |
Upadhyay ArunSee Remarks
|
Tax withholdingCommon Stock | 842 | $1.17 | $985.14 |
DisclosureSEC source: 0001062993-24-017006 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,830 Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:09 UTC |
Castillo KirstenDirector
|
GrantOption (Right to Buy) · Derivative | 66,929 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001062993-24-013296 · form4.xml · derivative · entry 1 Castillo Kirsten · CIK 0001808806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,929 Underlying: Common Stock · 66,929 shares Expires 2034-06-28 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 28, 2025 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 16:10 UTC |
WHITTINGTON MARNA CDirector
|
GrantOption (Right to Buy) · Derivative | 66,929 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001062993-24-013298 · form4.xml · derivative · entry 1 WHITTINGTON MARNA C · CIK 0001227918 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,929 Underlying: Common Stock · 66,929 shares Expires 2034-06-28 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 28, 2025 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:10 UTC |
Kompella UdayDirector
|
GrantOption (Right to Buy) · Derivative | 66,929 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001062993-24-013297 · form4.xml · derivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,929 Underlying: Common Stock · 66,929 shares Expires 2034-06-28 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 28, 2025 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:09 UTC |
Zhang JungeDirector
|
GrantOption (Right to Buy) · Derivative | 66,929 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001062993-24-013294 · form4.xml · derivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,929 Underlying: Common Stock · 66,929 shares Expires 2034-06-28 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 28, 2025 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:09 UTC |
Fernandes PrabhavathiDirector
|
GrantOption (Right to Buy) · Derivative | 66,929 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001062993-24-013293 · form4.xml · derivative · entry 1 Fernandes Prabhavathi · CIK 0001540883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,929 Underlying: Common Stock · 66,929 shares Expires 2034-06-28 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 28, 2025 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 17, 2024 Filed Jul 2, 2024 20:09 UTC |
Upadhyay ArunSee Remarks
|
Tax withholdingCommon Stock | 917 | $1.42 | $1,302.14 |
DisclosureSEC source: 0001062993-24-013292 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 348,672 Read SEC document |
| April 16, 2024 Filed Apr 17, 2024 17:41 UTC |
Qamar HumaChief Medical Officer
|
GrantOption (Right to Buy) · Derivative | 308,465 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001062993-24-008488 · form4.xml · derivative · entry 1 Qamar Huma · CIK 0002015296 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,465 Underlying: Common Stock · 308,465 shares Expires 2034-04-16 F1 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on April 16, 2025, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:47 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 180,204 | $0.65 | $117,673.21 |
DisclosureSEC source: 0001062993-24-000559 · form4.xml · nonDerivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,009,869 Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:47 UTC |
Upadhyay ArunSee Remarks
|
Tax withholdingCommon Stock | 41,633 | $0.65 | $27,186.35 |
DisclosureSEC source: 0001062993-24-000558 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,589 Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:05 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
GrantOption (Right to Buy) · Derivative | 492,126 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001062993-24-000474 · form4.xml · derivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492,126 Underlying: Common Stock · 492,126 shares Expires 2034-01-02 F1 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 2, 2025, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:04 UTC |
Upadhyay ArunSee Remarks
|
GrantOption (Right to Buy) · Derivative | 137,795 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001062993-24-000473 · form4.xml · derivative · entry 1 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,795 Underlying: Common Stock · 137,795 shares Expires 2034-01-02 F1 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 2, 2025, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 16, 2023 Filed Sep 19, 2023 20:01 UTC |
Upadhyay ArunSee Remarks
|
Tax withholdingCommon Stock | 842 | $0.41 | $345.22 |
DisclosureSEC source: 0001062993-23-018252 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,222 Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 20:24 UTC |
Upadhyay ArunChief Scientific Officer
|
Tax withholdingCommon Stock | 917 | $0.51 | $467.67 |
DisclosureSEC source: 0001062993-23-013810 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,064 Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:22 UTC |
Zhang JungeDirector
|
PurchaseCommon Stock | 200,278 | $0.50 | $99,998.81 |
DisclosureSEC source: 0001062993-23-013749 · form4.xml · nonDerivative · entry 1 Zhang Junge · CIK 0001790205 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By: Gupiao Trust Disclosed balance after: 1,077,182 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.4993 to $0.5034. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 09, 2023 Filed Jun 9, 2023 21:29 UTC |
Castillo KirstenDirector
|
GrantOption (Right to Buy) · Derivative | 112,205 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001104659-23-070028 · tm2318370-6_4seq1.xml · derivative · entry 1 Castillo Kirsten · CIK 0001808806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,205 Underlying: Common Stock · 112,205 shares Expires 2033-06-09 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 9, 2024 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 09, 2023 Filed Jun 9, 2023 17:25 UTC |
WHITTINGTON MARNA CDirector
|
GrantOption (Right to Buy) · Derivative | 112,205 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001104659-23-070020 · tm2318370-2_4seq1.xml · derivative · entry 1 WHITTINGTON MARNA C · CIK 0001227918 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,205 Underlying: Common Stock · 112,205 shares Expires 2033-06-09 F1 · derivative.exercise_date: The option vests upon the earlier of (a) June 9, 2024 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.